Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Marts 2021

Planlagt Fastgjort Låst Flyttet Genmab
1.5k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • JørgenVarnæsJ Offline
    JørgenVarnæsJ Offline
    JørgenVarnæs
    wrote on sidst redigeret af
    #741

    Gad vide, om der findes +100 point dage, ligesom vi har oplevet flere -100 dage her på det sidste?

    1 Reply Last reply
    0
    • E Offline
      E Offline
      E_L
      wrote on sidst redigeret af
      #742

      do you really need someone else to answer that question for you JV? 😉

      1 Reply Last reply
      0
      • E Offline
        E Offline
        E_L
        wrote on sidst redigeret af
        #743

        AACR21
        1574 - Preclinical evaluation of epcoritamab combined with standard of care therapies for the treatment of B-cell lymphomas https://www.abstractsonline.com/pp8/#!/9325/presentation/2679

        1 Reply Last reply
        0
        • JørgenVarnæsJ Offline
          JørgenVarnæsJ Offline
          JørgenVarnæs
          wrote on sidst redigeret af
          #744

          Indeed I do - I keep searching but come up empty handed every time

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #745

            lol

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #746

              AACR21 1846 - DuoBody-CD40×4-1BB (GEN1042) induces dendritic-cell maturation and enhances T-cell activation and effector functions in vitro by conditional CD40 and 4-1BB agonist activity https://www.abstractsonline.com/pp8/#!/9325/presentation/2903

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #747

                Uğur Şahin co-author

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #748

                  1048 - Targeting BCL-2 and CD38 in models of acute myeloid leukemia reduces tumour burden https://www.abstractsonline.com/pp8/#!/9325/presentation/1980 "This data supports that combination treatment with Venetoclax and Daratumumab could have an important clinical application in the treatment of AML."

                  1 Reply Last reply
                  0
                  • DarvinD Offline
                    DarvinD Offline
                    Darvin
                    wrote on sidst redigeret af
                    #749

                    Ja det er lidt træls at det som regel tager længere tid at kravle opad end at springe nedad 🙂

                    1 Reply Last reply
                    0
                    • DarvinD Offline
                      DarvinD Offline
                      Darvin
                      wrote on sidst redigeret af
                      #750

                      Genmab er jo ellers i god form 😉

                      1 Reply Last reply
                      0
                      • R Offline
                        R Offline
                        Raun
                        wrote on sidst redigeret af
                        #751

                        Jeg er nu ikke helt overbevist endnu, at vi har fundet en bund.... Genmab har bare fulgt det generelle marked igennem de seneste dage...

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #752

                          953 - Efficacy of amivantamab, a bispecific EGFR/MET antibody, correlates with EGFR expression and signaling in NSCLC models with wild-type EGFR https://www.abstractsonline.com/pp8/#!/9325/presentation/2464

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #753

                            anybody heard anything from the Investor Events Genmab joined this week? Carnegie ,
                            HC Wainwright ,
                            Barclays?

                            1 Reply Last reply
                            0
                            • S Offline
                              S Offline
                              Sukkeralf
                              wrote on sidst redigeret af
                              #754

                              No

                              1 Reply Last reply
                              0
                              • nohopeN Offline
                                nohopeN Offline
                                nohope
                                wrote on sidst redigeret af
                                #755

                                Hvis nu alle havde støttet op om forbuddet mod at sælge aktier billigere end man selv havde købt dem..

                                1 Reply Last reply
                                0
                                • G Offline
                                  G Offline
                                  gdn55
                                  wrote on sidst redigeret af
                                  #756

                                  Bare vent til de skal til at købe igen.

                                  1 Reply Last reply
                                  0
                                  • Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktør
                                    wrote on sidst redigeret af
                                    #757

                                    Pæn salgsblok i 2035 på 6600 stk.

                                    1 Reply Last reply
                                    0
                                    • Helge_LarsenPI-redaktørH Offline
                                      Helge_LarsenPI-redaktørH Offline
                                      Helge_LarsenPI-redaktør
                                      wrote on sidst redigeret af
                                      #758

                                      Slut: 2032

                                      1 Reply Last reply
                                      0
                                      • JørgenVarnæsJ Offline
                                        JørgenVarnæsJ Offline
                                        JørgenVarnæs
                                        wrote on sidst redigeret af
                                        #759

                                        nåja - bedre end et spark i tænderne

                                        1 Reply Last reply
                                        0
                                        • JørgenVarnæsJ Offline
                                          JørgenVarnæsJ Offline
                                          JørgenVarnæs
                                          wrote on sidst redigeret af
                                          #760

                                          så længe luk er over åbning skal det nok gå - men et decideret rebound skal vi nok kigge langt efter

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger